Systematic review, meta-analysis and economic modelling of ...

DOI: 10.3310/hta17010 Health Technology Assessment 2013 Vol. 17 No. 129. McCord JN. Ninety-minute exclusion of acute MI using cardiac markers. Cardiol Rev 2002;19:22–5.30. Mills NL. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarctionand death in patients with suspected acute coronary syndrome. JAMA 2011;305:1210–16.31. Mitchell AMG. Multimarker panel to rule out acute coronary syndromes in low-risk patients. AcadEmerg Med 2006;13:803–6.32. Mohler ER, III, Ryan T, Segar DS, Sawada SG, Sonel AF, Perkins L, et al. Clinical utility of troponin Tlevels and echocardiography in the emergency department. Am Heart J 1998;135:253–60.33. Nakata T, Hashimoto A, Hase M, Tsuchihashi K, Shimamoto K, Nakata T, et al. Human heart-typefatty acid-binding protein as an early diagnostic and prognostic marker in acute coronary syndrome.Cardiology 2003;99:96–104.34. Ooi SB, Lim YT, Lau TC, Chia BL, Pillai S, Liu T, et al. Value of troponin-T rapid assay, cardiac enzymes,electrocardiogram and history of chest pain in the initial diagnosis of myocardial infarction in theemergency department. Eur J Emerg Med 2000;7:91–8.35. Orak M, Ustundag M, Guloglu C, Ozhasenekler A, Alyan O, Kale E. The role of the heart-type fattyacid binding protein in the early diagnosis of acute coronary syndrome and its comparison withtroponin I and creatine kinase-MB isoform. Am J Emerg Med 2010;28:891–6.36. Panteghini M, Cuccia C, Pagani F, Turla C, Panteghini M, Cuccia C, et al. Comparison of thediagnostic performance of two rapid bedside biochemical assays in the early detection of acutemyocardial infarction. Clin Cardiol 1998;21:394–8.37. Penttilä K, Penttilä I, Bonnell R, Kerth P, Koukkunen H, Rantanen T, et al. Comparison of the troponinT and troponin I ELISA tests, as measured by microplate immunoassay techniques, in diagnosingacute myocardial infarction. Eur J Clin Chem Clin Biochem 1997;35:767–74.38. Pervae S, Anderson S. Comparative analysis of cardiac troponin I and creatine kinase-MB as markersof acute myocardial infarction. Clin Cardiol 1997;20:269–71.39. Pettersson T, Simonsson M, Mattsson E, Kerth P. Rapid bedside testing of CK-MB mass combinedwith myoglobin is more sensitive compared to troponin T alone for rule-out of acute myocardialinfarction. Br J Anaesth 1996;76(Suppl. 2):117.40. Polanczyk CA, Johnson PA, Cook EF, Lee TH, Polanczyk CA, Johnson PA, et al. A proposed strategyfor utilization of creatine kinase-MB and troponin I in the evaluation of acute chest pain. Am JCardiol 1999;83:1175–9.41. Polanczyk CA, Lee TH, Cook EF, Walls R, Wybenga D, Printy-Klein G, et al. Cardiac troponin I as apredictor of major cardiac events in emergency department patients with acute chest pain. J AmColl Cardiol 1998;32:8–14.42. Ravkilde J, Nissen H, rder M, Thygesen K, Ravkilde J, Nissen H, et al. Independent prognostic valueof serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels insuspected acute myocardial infarction. Analysis of 28 months of follow-up in 196 patients. J AmColl Cardiol 1995;25:574–81.43. Roberts R, Roberts R. Early diagnosis of myocardial infarction with MB CK isoforms. Clin Chim Acta1998;272:33–45.44. Ross G, Bever FN, Uddin Z, Hockman EM, Ross G, Bever FN, et al. Troponin I sensitivity andspecificity for the diagnosis of acute myocardial infarction. J Am Osteopath Assoc 2000;100:29–32.45. Sayre MR, Kaufmann KH, Chen I, Sperling M, Sidman RD, Diercks DB, et al. Measurement of cardiactroponin T is an effective method for predicting complications among emergency departmentpatients with chest pain. Ann Emerg Med 1998;31:539–49.© Queen’s Printer and Controller of HMSO 2013. This work was produced by Goodacre et al. under the terms of a commissioning contract issued by the Secretary of Statefor Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journalsprovided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should beaddressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton SciencePark, Southampton SO16 7NS, UK.145